STOCK TITAN

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CeriBell, Inc. filed a Form 144 notifying the proposed sale of 11,112 common shares via Fidelity Brokerage Services on or about 09/04/2025 on the NASDAQ. The filing reports an aggregate market value of $134,609.87 against 36,663,968 shares outstanding, indicating the shares represent approximately 0.03% of the outstanding common stock. The shares arise from option exercises: 1,472 shares from an option granted 07/07/2021 and 9,640 shares from an option granted 02/16/2023, with cash payment recorded on 09/04/2025. The filer reports no sales in the prior three months. The form contains standard representations about material nonpublic information and signature attestation.

CeriBell, Inc. ha depositato un Modulo 144 notificando la proposta di vendita di 11.112 azioni ordinarie tramite Fidelity Brokerage Services in data approssimativa 04/09/2025 sul NASDAQ. La comunicazione indica un valore di mercato aggregato di $134.609,87 rispetto a 36.663.968 azioni in circolazione, ovvero circa il 0,03% del capitale sociale ordinario. Le azioni derivano dall’esercizio di opzioni: 1.472 azioni da un’opzione concessa il 07/07/2021 e 9.640 azioni da un’opzione concessa il 16/02/2023, con pagamento in contanti registrato il 04/09/2025. Il dichiarante segnala nessuna vendita nei tre mesi precedenti. Il modulo include le consuete dichiarazioni relative a informazioni materiali non pubbliche e l’attestazione della firma.

CeriBell, Inc. presentó un Formulario 144 notificando la propuesta de venta de 11.112 acciones comunes a través de Fidelity Brokerage Services en o alrededor del 04/09/2025 en el NASDAQ. La presentación informa un valor de mercado agregado de $134.609,87 frente a 36.663.968 acciones en circulación, representando aproximadamente el 0,03% del capital social ordinario. Las acciones provienen del ejercicio de opciones: 1.472 acciones de una opción otorgada el 07/07/2021 y 9.640 acciones de una opción otorgada el 16/02/2023, con pago en efectivo registrado el 04/09/2025. El declarante informa no haber realizado ventas en los tres meses previos. El formulario contiene las representaciones estándar sobre información material no pública y la certificación de la firma.

CeriBell, Inc.는 NASDAQ에서 2025-09-04경 Fidelity Brokerage Services를 통해 11,112 보통주를 매각할 예정임을 통지하는 Form 144를 제출했습니다. 제출서에는 유통주식수 36,663,968주 대비 $134,609.87총 시가가 보고되어 해당 주식이 전체 보통주 약 0.03%에 해당함을 나타냅니다. 해당 주식은 옵션 행사로 발생했으며, 1,472주는 2021-07-07에 부여된 옵션에서, 9,640주는 2023-02-16에 부여된 옵션에서 각각 나오며 현금 지급은 2025-09-04에 기록되었습니다. 제출인은 최근 3개월간 매도 없음을 보고했습니다. 양식에는 비공개 주요 정보 및 서명 확인에 관한 표준 진술이 포함되어 있습니다.

CeriBell, Inc. a déposé un formulaire 144 notifiant la proposition de vente de 11 112 actions ordinaires via Fidelity Brokerage Services aux alentours du 04/09/2025 sur le NASDAQ. le dépôt indique une valeur de marché agrégée de 134 609,87 $ pour 36 663 968 actions en circulation, ce qui représente environ 0,03 % du capital social ordinaire. Les actions proviennent de l’exercice d’options : 1 472 actions d’une option attribuée le 07/07/2021 et 9 640 actions d’une option attribuée le 16/02/2023, le paiement en espèces ayant été enregistré le 04/09/2025. Le déclarant indique aucune vente au cours des trois mois précédents. Le formulaire contient les déclarations standard relatives aux informations matérielles non publiques et l’attestation de signature.

CeriBell, Inc. reichte ein Formular 144 ein, in dem der vorgeschlagene Verkauf von 11.112 Stammaktien über Fidelity Brokerage Services am oder um den 04.09.2025 an der NASDAQ angekündigt wird. Die Einreichung meldet einen aggregierten Marktwert von $134.609,87 bei 36.663.968 ausstehenden Aktien, was etwa 0,03% des ausstehenden Stammkapitals entspricht. Die Aktien resultieren aus Optionsausübungen: 1.472 Aktien stammen aus einer am 07.07.2021 gewährten Option und 9.640 Aktien aus einer am 16.02.2023 gewährten Option; die Barzahlung wurde am 04.09.2025 erfasst. Der Meldende gibt an, in den vorangegangenen drei Monaten keine Verkäufe getätigt zu haben. Das Formular enthält die üblichen Erklärungen zu nichtöffentlichen wesentlichen Informationen und die Unterschriftsbestätigung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale from exercised options; immaterial to market capitalization but relevant for short-term float.

The filing documents a planned sale of 11,112 shares worth $134,609.87, which is roughly 0.03% of the issuer's 36.66 million shares outstanding. These shares result from option exercises granted in 2021 and 2023 and will be sold through Fidelity on NASDAQ. From a capital-structure perspective, the amount is negligible relative to total outstanding shares and unlikely to move the stock price materially. The disclosure complies with Rule 144 timeliness and includes the standard attestation regarding material nonpublic information.

TL;DR: Filing meets Rule 144 disclosure norms; exercise-and-sale indicates routine insider liquidity, not an unusual governance event.

The notice indicates securities acquired via options and being sold shortly after exercise with cash payment recorded. The filer discloses no related sales in the past three months and includes the required attestations. This is a routine compliance disclosure showing an insider monetizing vested equity rather than signaling governance changes or unexpected departures.

CeriBell, Inc. ha depositato un Modulo 144 notificando la proposta di vendita di 11.112 azioni ordinarie tramite Fidelity Brokerage Services in data approssimativa 04/09/2025 sul NASDAQ. La comunicazione indica un valore di mercato aggregato di $134.609,87 rispetto a 36.663.968 azioni in circolazione, ovvero circa il 0,03% del capitale sociale ordinario. Le azioni derivano dall’esercizio di opzioni: 1.472 azioni da un’opzione concessa il 07/07/2021 e 9.640 azioni da un’opzione concessa il 16/02/2023, con pagamento in contanti registrato il 04/09/2025. Il dichiarante segnala nessuna vendita nei tre mesi precedenti. Il modulo include le consuete dichiarazioni relative a informazioni materiali non pubbliche e l’attestazione della firma.

CeriBell, Inc. presentó un Formulario 144 notificando la propuesta de venta de 11.112 acciones comunes a través de Fidelity Brokerage Services en o alrededor del 04/09/2025 en el NASDAQ. La presentación informa un valor de mercado agregado de $134.609,87 frente a 36.663.968 acciones en circulación, representando aproximadamente el 0,03% del capital social ordinario. Las acciones provienen del ejercicio de opciones: 1.472 acciones de una opción otorgada el 07/07/2021 y 9.640 acciones de una opción otorgada el 16/02/2023, con pago en efectivo registrado el 04/09/2025. El declarante informa no haber realizado ventas en los tres meses previos. El formulario contiene las representaciones estándar sobre información material no pública y la certificación de la firma.

CeriBell, Inc.는 NASDAQ에서 2025-09-04경 Fidelity Brokerage Services를 통해 11,112 보통주를 매각할 예정임을 통지하는 Form 144를 제출했습니다. 제출서에는 유통주식수 36,663,968주 대비 $134,609.87총 시가가 보고되어 해당 주식이 전체 보통주 약 0.03%에 해당함을 나타냅니다. 해당 주식은 옵션 행사로 발생했으며, 1,472주는 2021-07-07에 부여된 옵션에서, 9,640주는 2023-02-16에 부여된 옵션에서 각각 나오며 현금 지급은 2025-09-04에 기록되었습니다. 제출인은 최근 3개월간 매도 없음을 보고했습니다. 양식에는 비공개 주요 정보 및 서명 확인에 관한 표준 진술이 포함되어 있습니다.

CeriBell, Inc. a déposé un formulaire 144 notifiant la proposition de vente de 11 112 actions ordinaires via Fidelity Brokerage Services aux alentours du 04/09/2025 sur le NASDAQ. le dépôt indique une valeur de marché agrégée de 134 609,87 $ pour 36 663 968 actions en circulation, ce qui représente environ 0,03 % du capital social ordinaire. Les actions proviennent de l’exercice d’options : 1 472 actions d’une option attribuée le 07/07/2021 et 9 640 actions d’une option attribuée le 16/02/2023, le paiement en espèces ayant été enregistré le 04/09/2025. Le déclarant indique aucune vente au cours des trois mois précédents. Le formulaire contient les déclarations standard relatives aux informations matérielles non publiques et l’attestation de signature.

CeriBell, Inc. reichte ein Formular 144 ein, in dem der vorgeschlagene Verkauf von 11.112 Stammaktien über Fidelity Brokerage Services am oder um den 04.09.2025 an der NASDAQ angekündigt wird. Die Einreichung meldet einen aggregierten Marktwert von $134.609,87 bei 36.663.968 ausstehenden Aktien, was etwa 0,03% des ausstehenden Stammkapitals entspricht. Die Aktien resultieren aus Optionsausübungen: 1.472 Aktien stammen aus einer am 07.07.2021 gewährten Option und 9.640 Aktien aus einer am 16.02.2023 gewährten Option; die Barzahlung wurde am 04.09.2025 erfasst. Der Meldende gibt an, in den vorangegangenen drei Monaten keine Verkäufe getätigt zu haben. Das Formular enthält die üblichen Erklärungen zu nichtöffentlichen wesentlichen Informationen und die Unterschriftsbestätigung.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

452.07M
28.88M
10.39%
84.32%
3.46%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE